Rapport Therapeutics Inc (NAS:RAPP)
$ 41.96 -0.19 (-0.45%) Market Cap: 2.01 Bil Enterprise Value: 1.54 Bil PE Ratio: 0 PB Ratio: 4.26 GF Score: 14/100

Rapport Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 10, 2026 / 05:00 PM GMT
Release Date Price: $35.21 (-1.76%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RAPP.OQ - Rapport Therapeutics Inc
Rapport Therapeutics Inc Annual Shareholders Meeting
Jun 10, 2026 / 05:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to the 2026 Virtual Annual Meeting of Rapport Therapeutics, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the Annual Meeting interface.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, everyone. My name is Abe Cisse, Chief Executive Officer of Rapport Therapeutics, Inc. The meeting is now called to order. I've asked Jesse Fishman of Goodwin Proctor, LLP, our outside legal counsel, to record the minutes. It is a pleasure to welcome our stockholders to the annual
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot